The Science Works, The Math Doesn't: Capital concentration and escalating investor expectations prevent startups from funding the clinical trials needed to reach approval, regardless of scientific merit. We needed to find a solution and built a clinical trials platform in Kazakhstan, partnering with global biopharma to accelerate clinical programs. Built by biotech operators and investors, Vantage solves the cost and timeline crisis killing early-stage programs. Kazakhstan's fast-growing biomedical economy is the overlooked advantage that can make the math work too.

Kazakhstan is The Game Changer.

●   FDA-Aligned by Design: Protocols built on FDA compliance and protocol

●   2-3x Faster Launch: Streamlined approvals, accelerated recruitment

●   70-80% Cost Savings: Nationalized hospitals, structurally lower costs

●   Full Sovereign Backing: Government-operated healthcare ecosystem

250+ completed & ongoing trials in Kazakhstan | Accepted by FDA, EMA, NMPA, MHRA ==> Inclusive of Novartis, AstraZeneca, Bayer, Pfizer, Johnson & Johnson, Eli Lilly, Sanofi, Roche, and more!

Tigermed: Vantage’s global CRO partner, bringing world-class trial execution, monitoring, and regulatory expertise. Vantage handles infrastructure access, government support, and local trial management. Tigermed is a Top 10 Global CRO (#1 in Asia)  across 37 countries, has 831 active drug trials ongoing, and has completed 700+ successful FDA/EMA/NMPA inspections.

Vantage

Org chart

Teams

Offices

Vantage

Org chart

Teams

Offices

Related companies